A clinical and pharmacokinetic study of the combination of etravirine plus raltegravir in HIV patients with expanded intolerance or resistance

INTRODUCTION: The combination of etravirine (ETR) plus raltegravir (RAL) could be an option for HIV patients with resistance, intolerance or important interactions with other drugs. However, there are few data on the efficacy, safety and pharmacokinetics of this dual therapy, taking into account the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bañón, Sara, Moreno, Ana, Quereda, Carmen, Gomez, Cristina, Diaz de Santiago, Alberto, Perez-Elías, María J, Moreno, Santiago, Luis Casado, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P272
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225328/
https://www.ncbi.nlm.nih.gov/pubmed/25397548
http://dx.doi.org/10.7448/IAS.17.4.19804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225328/
https://www.ncbi.nlm.nih.gov/pubmed/25397548
http://dx.doi.org/10.7448/IAS.17.4.19804

Ejemplares similares